Prognostic Value of Plasma DPP4 Activity in ST-elevation Myocardial Infarction Patients
2017年7月18日 更新者:Li Jing Wei、Chinese PLA General Hospital
The Association Between Plasma DPP4 Activity And Prognosis of Patients With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Increased plasma DPP4 activity (DPP4a) could predict both subclinical and new-onset atherosclerosis, and our previous study has found that the DPP4a was significantly lower in MI patients compared with patients having chest pain or unstable angina alone, and DPP4a is associated with no-reflow and major bleeding events in STEMI patients during hospital stay.
As no-reflow phenomenon and major bleeding events independently associates with a worse in-hospital and long-term prognosis.
One may speculate that the DPP4a is associated with long-term follow-up adverse cardiovascular events in these patients.The hypothesis was tested in this study.
研究概览
研究类型
观察性的
注册 (实际的)
625
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不适用
有资格学习的性别
全部
取样方法
概率样本
研究人群
patients with STEMI who were admitted to the Chinese PLA General Hospital for PCI
描述
Inclusion Criteria:
- consecutive patients of acute STEMI come to our department,absent of cardiogenic shock, and survival for at least 24 h after PCI treatment.
Exclusion Criteria:
- patients with cancer, and patients who were taking a DPP4 inhibitoror a glucagon-like peptide-1 (GLP-1) analogue
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
major adverse cardiac or cerebrovascular events
大体时间:The median follow-up was 30 months
|
including cardiovascular death, non-fatal myocardial infarction, heart failure and stroke
|
The median follow-up was 30 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
non-cardiovascular death
大体时间:The median follow-up was 30 months
|
The median follow-up was 30 months
|
|
repeated revascularization
大体时间:The median follow-up was 30 months
|
defined as repeated PCI or bypass grafting of not only infarct related artery but also non-infarct related artery, driven by ischemic symptoms (stable/unstable angina or re-infarction) or detection of ischemia by non-invasive tests
|
The median follow-up was 30 months
|
stroke
大体时间:The median follow-up was 30 months
|
defined using the World Health Organization criteria
|
The median follow-up was 30 months
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Zheng TP, Liu YH, Yang LX, Qin SH, Liu HB. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of subclinical atherosclerosis in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study. Atherosclerosis. 2015 Oct;242(2):580-8. doi: 10.1016/j.atherosclerosis.2015.07.042. Epub 2015 Jul 26.
- Zheng TP, Yang F, Gao Y, Baskota A, Chen T, Tian HM, Ran XW. Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: A prospective study. Atherosclerosis. 2014 Aug;235(2):619-24. doi: 10.1016/j.atherosclerosis.2014.05.956. Epub 2014 Jun 8.
- Li JW, Chen YD, Chen WR, Jing J, Liu J, Yang YQ. Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients. Sci Rep. 2016 Dec 21;6:39412. doi: 10.1038/srep39412.
- Niccoli G, Kharbanda RK, Crea F, Banning AP. No-reflow: again prevention is better than treatment. Eur Heart J. 2010 Oct;31(20):2449-55. doi: 10.1093/eurheartj/ehq299. Epub 2010 Sep 13. No abstract available.
- Pellaton C, Cayla G, Silvain J, Zeymer U, Cohen M, Goldstein P, Huber K, Pollack C Jr, Kerneis M, Collet JP, Vicaut E, Montalescot G; ATOLL Investigators. Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial. Am Heart J. 2015 Oct;170(4):778-86. doi: 10.1016/j.ahj.2015.05.021. Epub 2015 Jul 3.
- Li JW, Chen YD, Chen WR, You Q, Li B, Zhou H, Zhang Y, Han TW. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction. Cardiovasc Diabetol. 2017 Jun 6;16(1):72. doi: 10.1186/s12933-017-0553-3.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2013年1月1日
初级完成 (实际的)
2015年9月30日
研究完成 (实际的)
2015年9月30日
研究注册日期
首次提交
2017年2月5日
首先提交符合 QC 标准的
2017年2月5日
首次发布 (估计)
2017年2月8日
研究记录更新
最后更新发布 (实际的)
2017年7月21日
上次提交的符合 QC 标准的更新
2017年7月18日
最后验证
2017年7月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
plasma DPP4 activity的临床试验
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Splendor-NC招聘中
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in Qatar撤销
-
First Affiliated Hospital, Sun Yat-Sen University完全的
-
The University of QueenslandBaxter Healthcare Corporation; Health Research Council, New Zealand; Australian Government Department...完全的
-
All India Institute of Medical Sciences, New DelhiPostgraduate Institute of Medical Education and Research; Jawaharlal Institute of Postgraduate... 和其他合作者完全的
-
Belfast Health and Social Care TrustQueen's University, Belfast; NHS Blood and Transplant; Northern Ireland Clinical Trials Unit招聘中